Furthermore, the diagnostic efficacy of cathepsin D concentration in extracellular vesicles as a criterion for distinguishing FTD patients from healthy controls was notably high (AUC = 0.85), exhibiting a sensitivity of 75.4% and a specificity of 76.7%. This evidence concerns the gene CTSD and frontotemporal dementia.